{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
cycrimine
to a specific field?
There is one exact (name or code) match for cycrimine
Status:
US Previously Marketed
Source:
PAGITANE by LILLY
(1953)
Source URL:
First approved in 1953
Source:
PAGITANE by LILLY
Source URL:
Class (Stereo):
CHEMICAL (RACEMIC)
Conditions:
CYCRIMINE is an antispasmodic drug used for the treatment of Parkinson's disease (PD). It binds the muscarinic acetylcholine receptor M1, effectively reducing levels of acetylcholine. This decrease in acetylcholine restores the normal dopamine-acetylcholine balance and relieves the symptoms of PD.
Showing 1 - 6 of 6 results
Status:
US Previously Marketed
Source:
PAGITANE by LILLY
(1953)
Source URL:
First approved in 1953
Source:
PAGITANE by LILLY
Source URL:
Class (Stereo):
CHEMICAL (RACEMIC)
Conditions:
CYCRIMINE is an antispasmodic drug used for the treatment of Parkinson's disease (PD). It binds the muscarinic acetylcholine receptor M1, effectively reducing levels of acetylcholine. This decrease in acetylcholine restores the normal dopamine-acetylcholine balance and relieves the symptoms of PD.
Status:
US Previously Marketed
Source:
PAGITANE by LILLY
(1953)
Source URL:
First approved in 1953
Source:
PAGITANE by LILLY
Source URL:
Class (Stereo):
CHEMICAL (RACEMIC)
Conditions:
CYCRIMINE is an antispasmodic drug used for the treatment of Parkinson's disease (PD). It binds the muscarinic acetylcholine receptor M1, effectively reducing levels of acetylcholine. This decrease in acetylcholine restores the normal dopamine-acetylcholine balance and relieves the symptoms of PD.
